VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
PR Newswire —
HENDERSON, Nev., Feb. 25, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is pleased to provide a consolidated update on the significant clinical and commercial progress achieved over recent months. Key Highlights:...